3Akima S, Hawthorne WJ, Favaloro E, et al. Tirofiban and activated protein C synergistically inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from allogeneic islet cells exposure to human blood [J]. Am J Transplant, 2009, 9 (7): 1533-1540.
4Bennet W, Groth CG, Larsson R, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes[J]. Ups J Med Sci, 2000, 105 (2): 125-133.
5Goto M, Tjemberg J, Dufrane D, et al. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation [J]. Xenotransplantation, 2008, 15 (4) : 225-234.
6Cabric S, Sanchez J, Lundgren T, et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation [J]. Diabetes, 2007, 56 (8): 2008-2015.
7Ozmen L, Ekdahl KN, Elgue G, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation [J]. Diabetes, 2002, 51 (6): 1779-1784.
8Prydz H, Camerer E, Rottingen JA, et al. Cellular consequences of the initiation of blood coagulation [J]. Thromb Haemost, 1999, 82 (2): 183-192.
9Prydz H. A new paradigm for blood coagulation research [J]. Thromb Haemost, 2000, 83 (4): 520, 522.
10Pendurthi UR, Rao LV. Factor Vlla/tissue factor-induced signaling: a link between clotting and disease [J]. Vitam Horm, 2002, 64: 323-355.
6Packham DK, Alves TP,Dwyer JP, et al. Relative incidence ofESRD versus cardiovascular mortality in proteinuric type 2diabetes and nephropathy: results from the DIAM ETRIC(Diabetes Mellitus Treatment for Renal InsufficiencyConsortium) database[ J J. Am J Kidney Dis, 2012, 59 (1) : 75-83.
7Nathan DM, Zinman B, Cleary PA, et al. Modern-day clinicalcourse of type 1 diabetes mellitus after 30 years?duration: thediabetes control and complications trial/epidemiology ofdiabetes interventions and complications and Pittsburghepidemiology of diab etes complications experience ( 1983-2005) [J]. Arch Intern Med,2009,169(14) : 1307-1316.
8De Zeeaw D, Remuzzi G,Parving HH, et al. Albuminuria atherapeutic target for cardiovascular protection in type 2diabetic patients with nephropathy[J]. Circulation, 2004,110(8):921-927.
9Lembert N, Wesche J, Petersen P,et al. Areal densitymeasurement is a convenient method for the determination ofporcine islet equivalents without counting and sizing individualislets[J]. Cell Transplant, 2003,12(1) : 33-41.
10Elmarakby AA, Sullivan JC. Relationship between oxidativestress and inflammatory cytokines in diabetic nephropathy[J].Cardiovasc Ther,2012,30(1)*49-59.
